13 April 2017
Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing
A new review study published on the ERS European Respiratory Review describes the importance of Cardio Pulmonary Exercise Test to evaluate dyspnoea symptoms in Interstitial lung diseases (ILDs) patients.
This review describes the respiratory physiology of ILD, both at rest and during exercise, and aims to provide comprehensive and updated evidence on the clinical utility of the cardiopulmonary exercise test in the assessment and management of these pathological entities. In addition, the role of exercise training and pulmonary rehabilitation programmes in the ILD population is addressed.
The study concludes that "CPET represents the gold standard, since it provides useful information on underlying causes through a comprehensive evaluation of all the systems involved in the pathophysiological response to exercise".
The article details are the following:
- Title: "Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing"
- Authors: Bonini M, Fiorenzano G
- Published in: Eur Respir Rev. 2017 Feb 21;26(143)
The study can be freely downloaded at the following link: click here
Founded in 1980, COSMED is a privately owned company manufacturing Cardio Pulmonary and Metabolic Diagnostic Equipment. COSMED products include a full range of Spirometers, Pulmonary Function, Body Composition, Nutritional Assessment and Cardio Pulmonary Exercise systems, including Electrocardiographs, Ergometers and Assessment Software. COSMED solutions are aimed for either professional or medical use for many different applications like: Hospital, Clinics, Primary Care, University & Education in Human Physiology, Clinical Nutrition, Commercial Weight Management, Human Performance Centers, Sport Institutions and Health Club Industry. COSMED Headquarters are located in the province of Rome, Italy. COSMED has subsidiaries in the USA, China and Germany, and distributes its products internationally through a constantly growing distributor network covering more than 70 countries.